Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JOINT-05 once-weekly teriparatide followed by alendronate vs alendronate monotherapy in high-risk primary osteoporosis
jRCTs031180235Completed
- Sponsor
- Public Health Research Foundation
- Start
- Dec 2014
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial in involutional osteoporosis comparing Sequential teriparatide then alendronate with Alendronate monotherapy (2 arms). Primary endpoint: Incidence of new vertebral fracture at 72 weeks. Started Dec 2014; status: completed.
02
Drugs
teriparatidealendronate
03
Conditions
involutional osteoporosis
Beyond the preview
Go deeper on jRCTs031180235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180235.